BIESF Stock Price, Chart, Stats & News
Biotest AG (BIESF) is a dividend-paying stock with a current dividend yield of 0.00% as of Jun 9, 2025. It pays $0 per share over the trailing twelve months and distributes annually. Its dividend has grown at a -6.94% 5-year compound annual rate.
Dividend safety
Dividend coverage looks healthy — BIESF pays out about 0% of earnings.
BIESF chart
About
Biotest Aktiengesellschaft, a German biopharmaceutical company established in Dreieich in 1946, specializes in the research, development, production, and global commercialization of advanced biological therapeutics. Its operations are organized into key segments: Therapy, Plasma & Services, and Other. The company’s primary focus areas encompass critical medical needs within hematology (blood disorders), clinical immunology, and intensive care medicine.
Related lists
Similar securities
Based on sector and market capitalization
